Abstract: An image capturing module includes a main casing, an image capturing unit, a knob cover, and at least one shielding structure. The image capturing unit is disposed in the main casing. The knob cover is rotatably connected to the main casing. The shielding structure is disposed on the main casing and movably connected to the knob cover. The knob cover drives the shielding structure to shield the image capturing unit. An electronic device including a display and the image capturing module is also provided.

Abstract: A display device includes a front frame, a middle frame, a panel assembly, a middle-rear frame, and a backlight assembly. The front frame includes a front-frame side plate and a front-frame edge plate connected to the front-frame side plate. The middle frame includes a middle-frame side plate and a middle-frame bottom plate connected to the middle-frame side plate, and the middle-frame side plate is adjacent to the front-frame side plate and the front-frame edge plate. The panel assembly is adjacent to the front-frame edge plate and the middle-frame side plate. The middle-rear frame has a middle-rear-frame side plate and a middle-rear-frame bottom plate connected to the middle-rear-frame side plate, and the middle-rear-frame side plate is adjacent to the middle-frame side plate and the middle-frame bottom plate. The backlight assembly is adjacent to the middle-frame bottom plate and the middle-rear-frame side plate.

Abstract: The present invention relates to a liquid, propellant-free pharmaceutical preparation and a method for administering a pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprises: (a) an active substance selected from umeclidinium bromide and vilanterol trifenatate and combinations thereof; (b) a solvent; (c) a pharmacologically acceptable solubilizing agent; and (d) a pharmacologically acceptable preservative, and optionally includes a pharmacologically acceptable stabilizer, a pharmacologically acceptable co-solvent, or other pharmacologically acceptable additives.

Abstract: An elevating mechanism adapted to accommodate a function unit and including main frame, elevating frame, and accommodation frame. The main frame has first guide portion including straight portion and non-straight portion. The elevating frame is movably disposed on the main frame. The accommodation frame is pivotably connected to the elevating frame and has second guide portion slidably located at the first guide portion. When the accommodation frame is in non-inclined position, the second guide portion is located at the straight portion. When the accommodation frame is in inclined position, the second guide portion is located at the non-straight portion and the accommodation frame is inclined with respect to the main frame.

Abstract: An elevating mechanism adapted to accommodate a function unit and including main frame, elevating frame, and accommodation frame. The main frame has first guide portion including straight portion and non-straight portion. The elevating frame is movably disposed on the main frame. The accommodation frame is pivotably connected to the elevating frame and has second guide portion slidably located at the first guide portion. When the accommodation frame is in non-inclined position, the second guide portion is located at the straight portion. When the accommodation frame is in inclined position, the second guide portion is located at the non-straight portion and the accommodation frame is inclined with respect to the main frame.

Abstract: The present invention discloses a liquid, propellant-free pharmaceutical preparation and a method for administering a pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprising: (a) active substances selected from glycopyrronium bromide and indacaterol maleate; (b) a solvent; and (c) a pharmacologically acceptable preservative, optionally including a pharmacologically acceptable stabilizer, a pharmacologically acceptable solubilizing agent, a pharmacologically acceptable co-solvent, or other pharmacologically acceptable additives.

Abstract: The present invention relates to a liquid, propellant-free pharmaceutical preparation and a method for administering a pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprises: (a) an active substance selected from umeclidinium bromide and vilanterol trifenatate and combinations thereof; (b) a solvent; (c) a pharmacologically acceptable solubilizing agent; and (d) a pharmacologically acceptable preservative, and optionally includes a pharmacologically acceptable stabilizer, a pharmacologically acceptable co-solvent, or other pharmacologically acceptable additives.